Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vimal Mehta Insider Profile
25 Followers
Vimal Mehta, CEO & President, Director, Ten Percent Owner at Bioxcel Therapeutics, holds 7.74M shares in Bioxcel Therapeutics (Ticker: BTAI).
Vimal Mehta Bioxcel Therapeutics (BTAI)CEO & President, Director, Ten Percent Owner
Bioxcel Therapeutics (BTAI)
CEO & President, Director, Ten Percent Owner
Ranked #143 out of 99,335 Corporate Insiders
Profitable Transactions
9 out of 10 Profitable Transactions
Average Return
+125.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO & President, Director, Ten Percent Owner
Roles that Vimal Mehta holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 19, 2019 - Aug 19, 2020
Return:+374.00%
The most profitable trade made by Vimal Mehta
Vimal Mehta's Trading History
List of latest transactions for each holding click on a transaction to see Vimal Mehta's performance on stock
You May Also Like
Vimal Mehta insider profile FAQ
What is the percentage of profitable transactions made by Vimal Mehta?
The percentage of profitable transactions made by Vimal Mehta is 90%.
What is the average return per transaction made by Vimal Mehta?
The average return per transaction made by Vimal Mehta is 125.20%.
What stocks does Vimal Mehta hold?
Vimal Mehta holds: BTAI stocks.
What was Vimal Mehta’s latest transaction?
Vimal Mehta latest transaction was an Uninformative Buy of $4.15K.
What was Vimal Mehta's most profitable transaction?
Vimal Mehta’s most profitable transaction was an Informative Buy of BTAI stock on August 19, 2019. The return on the trade was 374.00%.
What is Vimal Mehta's role in Bioxcel Therapeutics?
Vimal Mehta's role in Bioxcel Therapeutics is CEO & President, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.